11 – 20 of 591
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
(
- Contribution to journal › Article
-
Mark
The role of extracellular vesicle fusion with target cells in triggering systemic inflammation
(
- Contribution to journal › Article
-
Mark
Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
(
- Contribution to journal › Article
-
Mark
Current and emerging sequencing-based tools for precision cancer medicine
(
- Contribution to journal › Scientific review
-
Mark
Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma
2024) In Proceedings of the National Academy of Sciences of the United States of America 121(7). p.2310479121-2310479121(
- Contribution to journal › Article
-
Mark
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research
(
- Contribution to journal › Scientific review
-
Mark
Interleukin-1 receptor accessory protein (IL-1RAP) : A magic bullet candidate for immunotherapy of human malignancies
(
- Contribution to journal › Scientific review
-
Mark
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC) : a pooled analysis of seven studies
(
- Contribution to journal › Article
-
Mark
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma
(
- Contribution to journal › Article
-
Mark
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas
(
- Contribution to journal › Article